Rithmi · RITHMI: THE SMART MONITOR THAT TAKES CARE OF YOUR HEART

Arrhythmia Algorithm S.L. (https://rithmi.com) is a privately held company with the mission to support people to take care oftheir heart and prevent health problems as the stroke. Our aim is to revolutionize the way Auricular fibrillation is diagnosedthrough a comfortable, compliant and innovative method. After successfully piloting the prototype version of RITHMItechnology, the team can confirm the capability of its breakthrough product to open new markets in Europe with the potentialfor rapid growth. Rithmi is a pioneer in arrhythmia detection technologies and the leading company in ComputationalPredictive Care™. By pursuing the present feasibility study, RITHMI’s management team aims to improve its understandingof international market conditions and the associated risks that need to be considered as the company develops a deeperbusiness plan for rolling out, and scaling up RITHMI as a marketable innovative solution. SME Instrument Phase-1 andPhase-2 will be extremely beneficial in helping the company to accelerate development and market penetration of theRITHMI solution in target segments, boosting the company’s growth to 40-50 employees and over € 18,395,412 revenues by2023.